Equity Overview
Price & Market Data
Price: $1.24
Daily Change: $0.00 / 0.00%
Daily Range: $1.05 - $1.24
Market Cap: $2,226,122
Daily Volume: 27,747
Performance Metrics
1 Week: 11.23%
1 Month: -0.80%
3 Months: -14.48%
6 Months: -55.56%
1 Year: -75.51%
YTD: -14.48%
Company Details
Employees: 2
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.